Inflammaging in clinical practice recap
Every lecture and panel from the GlycanAge clinical day, captured with AI summaries, key takeaways and CME credit. Watch at your own pace.
- Sessions on demand
- 24 speakers
- 5 clinical modules
- 10 CME credits
Inflammaging: From Biological Theory to Measurable Aging · Claudio Franceschi · Free preview
The full programme, session by session
24 recorded talks and panels. Each one includes the recording, an AI-generated summary and the key clinical takeaways. Free preview sessions can be opened directly.
Inflammaging: From Biological Theory to Measurable Aging
How Antibody Glycosylation Controls Immune Activity
Glycans as Biomarkers of Aging and Disease Risk
Inflammation and the Future of Cardiovascular Prevention
Precision Geromedicine: Personalizing the Future of Healthy Aging
Why Glycans Matter in Precision and Preventive Medicine
Antibody Glycans in Autoimmunity and Inflammation Resolution
Toward Personalized Measurement and Treatment of Inflammaging
What Biological-Age Testing Reveals in Real Life
Using GlycanAge in Longevity Clinical Practice
Hormones, Inflammation, and the GlycanAge of Women
Mitochondrial Health, Molecular Hydrogen, and Healthy Aging
Sex Hormones and Immune Aging: A Clinical Panel
Beyond Weight Loss: A New Clinical Model for GLP-1 Therapy
Therapeutic Fasting for Metabolic Health and Healthy Aging
Detecting and Reversing Cardiometabolic Aging
Preserving Muscle and Metabolic Resilience During Weight Loss
Targeting Residual Inflammation in Cardiovascular Disease
The Biological Drivers and Clinical Biomarkers of Inflammaging
Bringing Biological-Age Testing Into Clinical Practice
When Training Volume Backfires: Using IgG Glycans to Detect Overtraining
Longevity in Sports Medicine: Precision Strategies for Performance and Recovery
Balancing Training, Recovery and Longevity: From Elite Athletes to Everyday Health
The end
AI session summary
Franceschi traces inflammaging from its origins as a theory of immune ageing to a measurable, modifiable driver of chronic disease. He frames low-grade chronic inflammation as the common soil linking cardiovascular disease, metabolic dysfunction and frailty, and argues that glycan-based and other molecular markers now make it trackable in routine clinical practice.
Key takeaways
- Inflammaging is a measurable process, not just a theory of ageing
- Low-grade chronic inflammation links cardiovascular, metabolic and frailty risk
- Glycan-based markers make immune ageing trackable in routine practice
- Intervening early reframes inflammation as a modifiable clinical target
Unlock access to all sessions
One pass opens lifetime access to every session recording, summary and resource from the event, on any device, whenever you need it.
- Sessions on demand
- AI summaries & takeaways
- Speaker transcripts
- 10 CME credits
- Downloadable slides
Buying for a clinic or team? Talk to us
The clinicians and researchers on the programme
World-leading voices in inflammaging, longevity medicine and glycoscience. Select any name for the full biography.